The company is looking to set up a lifestyle specific nutra plant in India, besides expanding the global business in onco nutrition, the company said in a statement.
It is also focusing on conducting country-specific clinical studies to take its products outside India, it added.
"We are looking to raise approximately Rs 25 crore in a timeline of next six to nine months," Esperer Bioresearch founder and CEO Raktim Chattopadhyay said.
The company has not raised any funds so far and has adopted internal seed funding, he added.
To address the nutritional deficiencies in cancer patients in India, the company launched two health supplements on Wednesday, Esperer Bioresearch said. PTI AKT RUJ MR MR
Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI